Mach-1 Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,091
Closed -$268K 163
2026
Q1
$268K Sell
3,091
-8,311
-73% -$796K 0.09% 138
2025
Q4
$1.1M Buy
11,402
+8,878
+352% +$862K 0.23% 86
2025
Q3
$240K Sell
2,524
-6,724
-73% -$618K 0.04% 203
2025
Q2
$806K Sell
9,248
-428
-4% -$36.3K 0.24% 100
2025
Q1
$870K Buy
+9,676
New +$866K 0.26% 102
2024
Q1
Sell
-23,282
Closed -$1.92M 157
2023
Q4
$1.92M Buy
23,282
+11,171
+92% +$851K 0.73% 37
2023
Q3
$949K Sell
12,111
-9,635
-44% -$807K 0.39% 64
2023
Q2
$1.92M Buy
21,746
+21,459
+7,477% +$1.85M 0.54% 45
2023
Q1
$20.7K Sell
287
-9,023
-97% -$735K 0.13% 90
2022
Q4
$724K Buy
9,310
+9,081
+3,966% +$736K 0.24% 81
2022
Q3
$18K Buy
229
+29
+15% +$2.61K 0.02% 171
2022
Q2
$17K Buy
+200
New +$20.3K 0.01% 189

Other funds holding MDT

Mach-1 Financial Group's MDT Position: Q2 2026 in Review

Mach-1 Financial Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 3,091 shares — an estimated $268K sold.

Mach-1 Financial Group first reported a position in MDT in Q2 2022 and held it in 12 quarters. The position peaked at $1.92M in Q4 2023. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Mach-1 Financial Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Mach-1 Financial Group sold 3,091 Medtronic shares in Q2 2026, an estimated $268K.
  • Mach-1 Financial Group first reported a position in Medtronic in Q2 2022 and held it in 12 quarters.
  • Mach-1 Financial Group's Medtronic position peaked at $1.92M in Q4 2023.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Mach-1 Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.